Logo
 
 

(CPIX, GCOM, EXEL) CRWENe
 
Rate This Video.
Save To Favorites
Add To Groups
Share
Post Video
Flag As
Inappropriate
Bookmarks
Similar Videos
Comments & Responses Post a Video Response

Video Description
Added On: February 9, 2012
By: karmastock
Views: 154
Comments: 0
Favorited: 0
Description:
On its Second Quarter Fiscal 2012, Globecomm Systems Inc - GCOM - posted revenue of $95.2 million, a 35.5% increase year over year. Exelixis Inc - EXEL - reported results for the fourth quarter 2011, posting revenues of $93.3 million, compared to $40.8 million for the comparable period in 2010. Cumberland Pharmaceuticals Inc - CPIX - reported that it has received a Notice of Allowance from the United States Patent and Trademark Office relating to its new formulation of Acetadote (acetylcysteine) Injection, which is used to treat acetaminophen poisoning. ********************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).
Category: News & Blogs
Tags: acetylcysteine acetaminophen Cumberland Pharmaceuticals Globecomm Exelixis GCOM EXEL CPIX Nasdaq:CPIX Nasdaq:EX
Rating:  (0 ratings)
Share and Embed!
Permanent Link on phpVID
(to link directly to this video or email it)
Embeddable Player
(add to your blog, website, social site, etc.)

More Videos By karmastock
Advertisement
 
© Copyright 2013, phpVID. All rights reserved. | Terms of Service | Privacy Policy | Contact Us | Advertise | Feedback